leqembi data is solid. 2 infusion sites. both full.

Company: Biogen

Posted by NeurologyRep_Biogen_NorCal_5521 · March 14, 2026

Tags: field, strategy, launch

CLARITY AD 18-month data is compelling.

neurologists who read it believe it.

but I'm detailing a drug to accounts that can't operationally use it.

that's an access infrastructure problem.

not a clinical story problem.

need site development support not more leave-behinds.

9 upvotes · 5 comments

More from Biogen